<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01200251</url>
  </required_header>
  <id_info>
    <org_study_id>9459</org_study_id>
    <secondary_id>71320</secondary_id>
    <nct_id>NCT01200251</nct_id>
  </id_info>
  <brief_title>Study of Bimatoprost Gel on Eyelash Growth</brief_title>
  <official_title>The Role of Bimatoprost Eyelash Gel in Chemotherapy-induced Madarosis: an Analysis of Efficacy and Safety</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A internally controlled, single-blinded, randomized controlled trial to investigate the use
      of Bimatoprost eyelash gel on eyelash growth and appearance in breast cancer patients who
      suffer from madarosis (loss of eyelashes) due to the side effects of chemotherapy. IND and
      IRB approval have been obtained.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2007</start_date>
  <completion_date type="Actual">December 2008</completion_date>
  <primary_completion_date type="Actual">September 2007</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>eyelash length</measure>
    <time_frame>6 months</time_frame>
    <description>eyelash ruler used to measure eyelash length</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>eyelash pigment</measure>
    <time_frame>6 mos</time_frame>
    <description>blinded grader used digital photos to grade degree of pigment on scale of 1-5</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>eyelash thickness</measure>
    <time_frame>6 mos</time_frame>
    <description>blinded grader used digital photos to grade degree of thickness on scale of 1-5</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>eyelash amount</measure>
    <time_frame>6 mos</time_frame>
    <description>blinded grader used digital photos to grade degree of amount by counting lashes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>eyelash side effects</measure>
    <time_frame>6 mos</time_frame>
    <description>any side effects (irritation, allergy, iop change, visual acuity, macular edema, uveitis, iris color change, etc... were assessed</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Madarosis</condition>
  <condition>Hypotrichosis</condition>
  <arm_group>
    <arm_group_label>Bimatoprost treated eyelid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>one eyelid of the patient was randomized to the treatment arm and given the gel to use</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control arm - no gel</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>the other fellow eyelid of the patient did not receive any treatment until month 4 and the patient crossed over to treating both eyelids</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bimatoprost eyelash gel</intervention_name>
    <description>Bimatoprost 0.03% solution was compounded into a gel - patients used on eyelash margin once daily placing gel with a fingertip or Q-tip for 6 months</description>
    <arm_group_label>Bimatoprost treated eyelid</arm_group_label>
    <other_name>lumigan</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-80 YO females

          -  madarosis or hypotrichosis (loss of eyelashes) due to chemotherapy used to treat
             breast cancer

          -  only breast cancer patients

        Exclusion Criteria:

          -  inability to follow up, apply gel

          -  active eye/eyelid infection or inflammatory process

          -  cancer not related to breast cancer, healthy patients

          -  males
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Tosti A, Pazzaglia M, Voudouris S, Tosti G. Hypertrichosis of the eyelashes caused by bimatoprost. J Am Acad Dermatol. 2004 Nov;51(5 Suppl):S149-50. Erratum in: J Am Acad Dermatol. 2004 Dec;51(6):1040.</citation>
    <PMID>15577756</PMID>
  </results_reference>
  <verification_date>September 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 10, 2010</study_first_submitted>
  <study_first_submitted_qc>September 10, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 13, 2010</study_first_posted>
  <last_update_submitted>July 14, 2014</last_update_submitted>
  <last_update_submitted_qc>July 14, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 16, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypotrichosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bimatoprost</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

